ROTEM® Obstetric Hemorrhage Pilot Study

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

March 1, 2022

Conditions
High Risk Postpartum Hemorrhage (PPH)
Interventions
DEVICE

ROTEM - rotation thromboelastometry testing

The ROTEM® is a simple blood test that provides information about specific components involved in blood clotting and stopping hemorrhage.

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT04409015 - ROTEM® Obstetric Hemorrhage Pilot Study | Biotech Hunter | Biotech Hunter